IDIX—As previously posted, I think Klarman did a deep dive into the IP landscape for HCV nukes and concluded that IDIX has a chance to extract some kind of meaningful settlement (or royalty) from GILD. MRK evidently thinks so too.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.